TABLE 1.

Kinetic Analysis Results

Patient no.SexVTK1K1/k2BPNDvB
EC-07F1.171.620.511.310.15
EC-10M0.631.420.281.230.16
EC-13F0.991.580.421.340.18
EC-20M1.202.670.392.120.18
EC-23M0.831.260.311.660.13
CIG-12M1.102.710.570.930.14
CIG-14M4.742.293.420.390.14
CIG-17M1.143.240.521.210.16
CIG-22F1.452.700.661.290.11
CIG-24F1.061.620.511.090.15
CON-01F1.151.950.580.980.18
CON-03M1.041.850.481.170.15
CON-05M0.911.370.401.270.15
CON-06F1.533.190.741.070.17
CON-09M1.181.620.561.130.13
ECs0.97 ± 0.241.71 ± 0.560.38 ± 0.09*1.53 ± 0.37*0.16 ± 0.02
CIGs1.90 ± 1.602.51 ± 0.601.13 ± 1.280.98 ± 0.360.14 ± 0.02
CONs1.16 ± 0.231.99 ± 0.700.55 ± 0.131.12 ± 0.110.16 ± 0.02
All1.34 ± 0.972.07 ± 0.670.69 ± 0.771.21 ± 0.370.15 ± 0.02
P0.360.090.030.020.31
  • * P < 0.05 on comparison between ECs and NUs.

  • EC = EC user; CIG = combustible cigarette user; CON = control.

  • Data are mean values and mean ± SD. P values are from Kruskal–Wallis test comparing 3 groups.